RUNX1 haploinsufficiency results in granulocyte colony-stimulating factor hypersensitivity - Top-Institutions - MDSpire

RUNX1 haploinsufficiency results in granulocyte colony-stimulating factor hypersensitivity

  • By

  • D W L Chin

  • M Sakurai

  • G S S Nah

  • L Du

  • B Jacob

  • T Yokomizo

  • T Matsumura

  • T Suda

  • G Huang

  • X-Y Fu

  • Y Ito

  • H Nakajima

  • M Osato

  • January 8, 2016

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Genetics

  • #2

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Stem Cell Biology
    • Immunology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Molecular Oncology
    • Genomics

  • #4

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Cancer Biology
    • Hematology
    • Genetics

  • #5

    University of Washington School of Medicine
    University of Washington School of Medicine

    Seattle, WA

    Key Differentiators

    • Hematology
    • Molecular Genetics
    • Stem Cell Research

Original Source(s)

RUNX1 haploinsufficiency results in granulocyte colony-stimulating factor hypersensitivity

  • by D W L Chin, M Sakurai, G S S Nah, L Du, B Jacob, T Yokomizo, T Matsumura, T Suda, G Huang, X-Y Fu, Y Ito, H Nakajima, M Osato

  • January 8, 2016

Related Content

Genetically determined telomere length and risk for haematologic diseases: results from large prospective cohorts and Mendelian Randomization analysis

Roswell Park is Hiring!

Working at Roswell Park will afford you incredible opportunities to work alongside some of the nation’s foremost clinicians and researchers to broaden your career experiences and be part of a team that eases the burden of cancer.

  • by

  • May 19, 2025

  • 1 min
CRISPR Enables In Vivo CAR T Cell Production

In vivo gene editing strategy generates CAR T cells directly inside the body – sidestepping costly manufacturing

  • March 30, 2026

  • 2 min